Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/26/2003EP1364962A1 Use of monocarboxylate transporter proteins for thyroid hormone transport
11/26/2003EP1364961A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained
11/26/2003EP1364657A1 Remedies for tumor in hematopoietic organs
11/26/2003EP1364656A2 Use of bone morphogenetic proteins for healing and repair of connective tissue attachment
11/26/2003EP1364655A1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
11/26/2003EP1364653A1 Casoase 3 inhibitors
11/26/2003EP1364578A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof
11/26/2003EP1364067A2 Prc17: an amplified cancer gene
11/26/2003EP1364055A2 Solubility reporter gene constructs
11/26/2003EP1364038A2 Adenovirus particles with mutagenized fiber proteins
11/26/2003EP1364037A2 Methods and compositions useful for stimulating an immune response
11/26/2003EP1364035A1 Vectors capable of imparting herbicide resistance and viral cross protection and methods
11/26/2003EP1364033A2 Floral development genes
11/26/2003EP1364032A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364030A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/26/2003EP1364029A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture
11/26/2003EP1364027A2 Zinc finger binding domains for nucleotide sequence ann
11/26/2003EP1364026A2 Human g protein-coupled receptor
11/26/2003EP1364025A1 A novel gene bn01 mapping to chromosome 16q24.3
11/26/2003EP1364024A2 Endogenous and non-endogenous versions of human g protein-coupled receptors
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364022A2 Human leucine-rich repeat containing protein, hlrrbm1, expressed predominately in bone marrow
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364020A2 Position dependent recognition of gnn nucleotide triplets by zinc fingers
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364016A2 Secreted proteins and their uses
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364013A1 G protein-coupled receptor
11/26/2003EP1364012A2 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
11/26/2003EP1364011A2 Modified thrombopoietin with reduced immunogenicity
11/26/2003EP1364007A1 Circular extra-chromosomal dna elements
11/26/2003EP1364004A2 Administration of nucleic acid sequence to female animal
11/26/2003EP1364003A2 G-protein fusion receptors and chimeric gaba b receptors
11/26/2003EP1364002A2 Process for the preparation of neutrophil inhibitory factor
11/26/2003EP1363954A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/26/2003EP1363949A1 Functional fragment of the leptine receptor
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363947A2 The guinea pig proteinase-activated receptor 4 and its activating peptide
11/26/2003EP1363945A2 Modified derivatives of cck-8
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363941A2 Histidine phosphatase interacting protein of 120 kd
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363939A2 Peptides for use in the treatment of alzheimer's disease
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP1363934A1 Template-fixed peptidomimetics with antimicrobial activity
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363929A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/26/2003EP1363920A1 Modified psma ligands and uses related thereto
11/26/2003EP1363677A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing
11/26/2003EP1363675A2 Compositions useful in gene therapy
11/26/2003EP1363664A2 Synthetic vaccine agents
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/26/2003EP1363660A2 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
11/26/2003EP1363658A2 Local pain-combating agent
11/26/2003EP1363655A2 Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof
11/26/2003EP1363643A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP0871492B1 Mesothelium antigen and methods and kits for targeting it
11/26/2003EP0859627B1 Mimicking peptides in cancer therapy
11/26/2003EP0759693B1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458976A Permeases 2,5-DKG
11/26/2003CN1458936A HIV peptides from Tat, Rev and Nef conserved regions and their application as E.G. vaccine components
11/26/2003CN1458935A Integrain binding motif containing peptides and methods of treating skeletal diseases
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458839A Dental products comprising bone growth enhancing peptide
11/26/2003CN1458170A New human protein with cancer inhibiting function and its encoding sequence
11/26/2003CN1458169A New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence
11/26/2003CN1458168A Recombined pig influenza virus NP antigen, its preparing method and use in diagnosis
11/26/2003CN1458167A Truncated express pig gyrate virus Ôàí type capsid protein antigen and its use
11/26/2003CN1458166A Rondom polypeptide library constructing method
11/26/2003CN1458165A Poly peptide matter and its preparing method and use
11/26/2003CN1458161A Process for producing human insulin using transgenic tomato
11/26/2003CN1458160A Gene recombination tumour blood vessel death factor PFK and its derivative fusion protein
11/26/2003CN1457879A Meningococcal vaccine and its preparing method
11/26/2003CN1457634A Mouse model of hipatitis B virus gene positioning integration to result in liver cell callcer
11/26/2003CN1128876C Transferrin receptor genes of moraxella
11/26/2003CN1128811C Process for directly enriching nerve growth factor from raw venin
11/25/2003US6653533 Vectors comprising foreign nucleotide sequence; transcription factors that enhance activation of defense mechanisms
11/25/2003US6653527 Isolated nucleic acid encoding the N-terminal amino acids of a COP1 protein; transforming cells; Arabidopsis, spinach, tomatoes, rice
11/25/2003US6653465 Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2
11/25/2003US6653464 Isolated nucleic acid encoding polypeptide of given sequence; use in diagnosis of infection in patients with neuropsychiatric disorders; treatment of central nervous system diseases
11/25/2003US6653463 Biocidal protein
11/25/2003US6653461 Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis
11/25/2003US6653460 Voltage-gated calcium channel antagonist and method
11/25/2003US6653450 Mutated recombinant collagens
11/25/2003US6653449 Isolated from jellyfish; use in development of drugs for treatment of sting injuries and in pharmaceuticals where platelet agglutination is desired
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same